Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100053517Phase 4Recruiting
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: visual analogue scale for pain. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100053517.